Siga Technologies INC Cash and Restricted Cash
Siga Technologies INC (SIGA) had Cash and Restricted Cash of $117.58 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $117.58M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $145.56M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $154.97M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $171.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $117.58M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $145.56M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $154.97M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $171.96M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $182.46M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $162.27M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $155.40M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $99.27M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $106.95M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $143.87M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $150.15M 10-K · filed 2026-03-10 |
| 2023-09-30 | $71.11M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $76.21M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $115.68M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $98.79M 10-K · filed 2026-03-10 |
| 2022-09-30 | $109.75M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $114.53M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $153.26M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $103.14M 10-K · filed 2025-03-11 |
| 2021-09-30 | $92.82M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $98.49M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $106.53M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $117.89M 10-K · filed 2024-03-12 |
| 2020-09-30 | $78.66M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $53.07M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $77.38M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $160.99M 10-K · filed 2023-03-02 |
| 2019-09-30 | $176.23M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $175.99M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $180.34M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $180.40M 10-K · filed 2022-03-03 |
| 2018-09-30 | $108.08M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $23.31M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $28.54M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $37.10M 10-K · filed 2021-03-04 |
| 2017-09-30 | $45.64M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $53.28M 10-Q · filed 2018-08-07 |
| 2017-03-31 | $55.05M 10-Q · filed 2018-05-04 |
| 2016-12-31 | $56.17M 10-K · filed 2020-03-05 |
| 2015-12-31 | $112.71M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |